Published Reported
TRT UK: What Is TRT and Who Should Take a TRT Test? A Complete UK Guide
Research suggests that 1 in 4 UK men over 40 suffer from low testosterone.
In The News
Published Reported
Research suggests that 1 in 4 UK men over 40 suffer from low testosterone.
Published Reported
The NHS reference range for testosterone is very broad, so a man can be within it and still have symptoms of low testosterone, and the answer to whether low testosterone is causing a man's symptoms is, more often...
Published Reported
Average male testosterone has declined about 1% per year for decades, so that a 30-year-old today may have the testosterone level of his grandfather at age 50; enclomiphene is offered as an 'Oral Testosterone...
Published Reported
Symptoms alone are not enough to diagnose low testosterone, hematocrit above 54% is a contraindication, testosterone can suppress LH and FSH and impair fertility, and compounded testosterone and enclomiphene are not...
Published Reported
All exogenous testosterone suppresses spermatogenesis, and for patients who wish to preserve fertility, off-label clomiphene, hCG or enclomiphene may be considered.
Published Reported
Oral enclomiphene is a clinically studied medication that supports natural testosterone production while avoiding the fertility suppression and testicular atrophy associated with conventional testosterone therapy.
Published Reported
Interviews with 9 Australian men using testosterone therapy found that access barriers led some to adjust doses themselves or combine prescribed testosterone with unregulated products.
Published Reported
Private clinics are prescribing testosterone to men without medical need, including men with normal levels, exposing them to infertility and thickened blood, whereas testosterone is needed by men with true hypogonadism.
Published Reported
An FDA expert panel concluded that testosterone therapy does not increase cardiovascular risk or prostate cancer risk; 2026 brings Kyzatrex, a new FDA-approved oral testosterone launching in 2026.
Published Reported
Testosterone therapy was not associated with an increased risk of major adverse cardiovascular events, but pulmonary embolism and atrial fibrillation were more frequent in the treatment group.
Shared Decision Making
Use our patient resources and questionnaires to prepare questions about symptoms, testing and treatment options for your doctor.
Create a free account or log in to save and bookmark articles.